Search for: "KING PHARMACEUTICALS, INC."
Results 61 - 80
of 211
Sorted by Relevance
|
Sort by Date
7 Nov 2014, 5:52 am
King-Washington v. [read post]
1 Sep 2010, 4:46 pm
This note is likely to be published because its subject matter relates to Deep-sea Horizon. http://www.patentlyo.com/patent/2010/08/transocean-v-maersk-speeding-up-deepsea-drilling.html Expanding the Printed Matter Exclusion: King Pharmaceuticals, Inc. v. [read post]
13 Aug 2009, 4:07 am
Janssen Pharmaceutical, Inc., ___ A.2d ___, 2009 WL 1857395 (Pa. [read post]
5 Apr 2016, 2:12 am
At the petition stage, briefs have also been filed by the Generic Pharmaceutical Association PhRMA, WLF, and the Nat’l Assn of Manufacturers. = = = = = [1] King Drug Co. of Florence, Inc. v. [read post]
28 Jan 2020, 12:06 am
EventsIP Law Reading Group - King's College LondonThe IP Law Reading Group is back and will be covering the timely topic of 'IP Law and Gender' in its first session in the new year! [read post]
5 Oct 2016, 11:44 am
The phrase “qui tam” is an abbreviation of a Latin phrase meaning “he who sues in this matter for the king as well as for himself. [read post]
5 Oct 2016, 11:44 am
The phrase “qui tam” is an abbreviation of a Latin phrase meaning “he who sues in this matter for the king as well as for himself. [read post]
10 Jul 2008, 5:31 pm
Super. 2006).Tennessee: King v. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
30 Jan 2013, 1:47 pm
Ohio 2010) (applying Ohio law); King v. [read post]
2 May 2010, 1:55 pm
Middlebrook Pharmaceuticals, Inc. [read post]
2 Jun 2011, 12:46 pm
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
2 Dec 2011, 2:00 pm
July 25, 2011); King v. [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid:… [read post]
2 Nov 2012, 11:58 am
Boehringer Ingelheim Pharmaceuticals, Inc., 2009 WL 702007, at *3-4 (D. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
10 Feb 2012, 11:54 am
” The AP continues, “The government said Wednesday that Dava Pharmaceuticals Inc. agreed to the settlement over charges that it violated the False Claims Act by misreporting drug prices to reduce its Medicaid Drug Rebate obligations. [read post]
28 Sep 2016, 8:39 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
18 Sep 2016, 6:03 pm
Teva Pharmaceuticals USA, Inc., et al. [read post]
